Literature DB >> 28960151

Brainstem pilocytic astrocytoma with H3 K27M mutation: case report.

Shuhei Morita1, Masayuki Nitta1,2, Yoshihiro Muragaki1,2, Takashi Komori3, Kenta Masui4, Takashi Maruyama1,2, Koichi Ichimura5, Yoshiko Nakano5, Tatsuo Sawada4, Shunichi Koriyama1, Shunsuke Tsuzuki1, Takayuki Yasuda1, Kazutoshi Hashimoto1, Akihiro Niwa1, Takakazu Kawamata1.   

Abstract

In this report, the authors present the first case of adult brainstem pilocytic astrocytoma (PA) with the H3 K27M mutation. A 53-year-old man was incidentally found to have a 2.5-cm partially enhanced tumor in the tectum on MRI. The enhancement in the lesion increased over 3 years, and gross-total removal was performed via the occipital transtentorial approach. The resected tissue indicated PA, WHO Grade I, and genetic analysis revealed the H3 K27M mutation. However, although the radiological, surgical, and pathological findings all corresponded to PA, this entity can easily be misdiagnosed as diffuse midline glioma with the H3 K27M mutation, which is classified as a WHO Grade IV tumor according to the updated classification. This case highlights the phenotypic spectrum of PA, as well as the biology of the H3 K27M-mutated gliomas, and may prove to be an exception to the rule that diffuse midline gliomas with the H3 K27M mutation behave in an aggressive manner. Based on the findings of this case, the authors conclude that, in addition to detecting the existence of the H3 K27M mutation, an integrated approach in which a combination of clinical, pathological, and genetic information is used should be applied for accurate diagnosis and determination of the appropriate treatment for diffuse midline gliomas.

Entities:  

Keywords:  H3 = histone 3; H3 K27M mutation; MET-PET = methionine-PET; PA = pilocytic astrocytoma; diffuse midline glioma; oncology; pilocytic astrocytoma

Mesh:

Substances:

Year:  2017        PMID: 28960151     DOI: 10.3171/2017.4.JNS162443

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

1.  Pineal region glioblastomas display features of diffuse midline and non-midline gliomas.

Authors:  Randy S D'Amico; George Zanazzi; Peter Wu; Peter Canoll; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2018-07-10       Impact factor: 4.130

2.  Clinical Significance of Molecular Diagnosis of Pilocytic Astrocytoma: A Case Report.

Authors:  Takahiro Ono; Masataka Takahashi; Junya Hatakeyama; Masaya Oda; Felix Sahm; Hiroshi Nanjo; Andreas von Deimling; Hiroaki Shimizu
Journal:  NMC Case Rep J       Date:  2019-06-05

3.  Adult pilocytic astrocytoma in the molecular era: a comprehensive review.

Authors:  Timothy A Gregory; Lyndon B Chumbley; John W Henson; Brett J Theeler
Journal:  CNS Oncol       Date:  2021-01-15

4.  Thoracic low grade glial neoplasm with concurrent H3 K27M and PTPN11 mutations.

Authors:  Michael G Argenziano; Julia L Furnari; Michael L Miller; Yu Sun; Matei A Banu; Justin A Neira; Matija Snuderl; Jeffrey N Bruce; Mary Welch; Paul McCormick; Peter Canoll
Journal:  Acta Neuropathol Commun       Date:  2022-04-28       Impact factor: 7.578

5.  H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis.

Authors:  Bette K Kleinschmidt-DeMasters; Jean M Mulcahy Levy
Journal:  Clin Neuropathol       Date:  2018 Mar/Apr       Impact factor: 1.368

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.